IDPC Publications

A key role and added value of IDPC is the production of policy analysis for a broad range of audiences including academia, civil society and policy makers. The majority of these publications are collaborations with members and partners, and are translated into multiple languages to support and facilitate advocacy.

Results 1 to 12 of 460

16 September 2024

Summary of the intersessional panel discussion on human rights challenges in addressing and countering all aspects of the world drug problem - Report of the OHCHR

The OHCHR summarises discussions on the need for a rights- and evidence- based approach to drug policy, including decriminalisation, harm reduction, legal regulation and structural changes to the global drug control regime.

11 September 2024

The crisis of overcrowded prisons in Indonesia: Barriers to accessing alternatives to imprisonment

IDPC and LBHM critically assess the country's punitive drug policies and their impact on prison overcrowding, recommending increased health-oriented provision and legal reforms.

11 September 2024

Drug laws in Thailand: the limits of reforms to relieve prison overcrowding

IDPC discusses alternative measures to incarceration implemented in Thailand from the perspectives of practitioners and people involved in the criminal legal system.

13 August 2024

IDPC Progress Report 2023-2024

IDPC reflects the network's collective efforts toward a world where responses to drug use, cultivation, production and supply are shaped by well-being, solidarity, evidence and compassion.

13 August 2024

Communication to the UN CESCR regarding Honduras periodic review on the right to health of people who use drugs

IDPC and LANPUD focus on key health indicators, impact on criminalisation and stigma, and availability of harm reduction services in Honduras.

13 August 2024

The ‘Vienna Spirit’ shatters: Report of the 67th session of the UN Commission on Narcotic Drugs and its high-level segment

IDPC highlights growing tensions at the latest CND session, where geopolitical divides and challenges to the punitive drug control paradigm were prominent and potentiated by civil society.

8 July 2024

Reforming drug laws to address racial injustice - Submission to the UN Committee on the Elimination of Racial Discrimination (CERD)

Release, Amnesty International, UNJUST UK, HRI and IDPC shed light on racial disparities in drug policing and associated human rights violations, urging for decriminalisation, the redirection of resources into care systems, and equitable reform.

25 June 2024

LGBTQI+ people who use drugs in Thailand: Advocacy for improved health and human rights responses

APCOM and IDPC urge the public, law enforcement, and policymakers in Thailand to help ensure equality and equity for LGBTQ+ people who use drugs, especially in their access to health and social services, and ending stigma and discrimination against them.

30 May 2024

IDPC contribution to the Global Coalition to Address Synthetic Drug Threats

IDPC recommends improving data collection, prioritising health-based responses, reviewing drug policy frameworks and ensuring robust civil society engagement.

29 May 2024

National stakeholder dialogue: Towards a stigma reduction roadmap for people who use drugs in Ghana

UNAIDS Ghana and IDPC bring together key actors to identify priorities for tackling stigma surrounding people who use drugs, including education, training, and policy reform.

16 April 2024

Decriminalising drug use and sex work to end the criminalisation of poverty and homelessness - Submission to the UNSRs on the right to adequate housing and on extreme poverty and human rights

IDPC and other organisations encourage the Special Rapporteurs to acknowledge the harmful effects of criminalising drug use and sex work in relation to the policing of people living in poverty in public spaces.

9 April 2024

For a drug policy that makes Europe safer, healthier, and more just - Drug policy manifesto for the 2024 European Parliament elections

Over 30 European organisations acknowledge the failure of drug policies and demand a new approach prioritising health, rights, and community participation